Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000914208-26-000448·Phathom Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
Phathom Pharmaceuticals Inc
Common Stock · CUSIP: 71722W107
Event date: 2026-09-30
- Filing-level shares
- 30,562.00
- Percent of class
- 0.0%
- Invesco Ltd.
Shares: 30,562.00 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000914208-26-000448
- Form type
- SCHEDULE 13G/A
- Filer
- Phathom Pharmaceuticals, Inc.
- CIK
- CIK 1783183
- Filed
- Nov 10, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership